Does BIMEKIZUMAB Cause Chronic obstructive pulmonary disease? 14 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Chronic obstructive pulmonary disease have been filed in association with BIMEKIZUMAB (Bimzelx). This represents 0.6% of all adverse event reports for BIMEKIZUMAB.
14
Reports of Chronic obstructive pulmonary disease with BIMEKIZUMAB
0.6%
of all BIMEKIZUMAB reports
0
Deaths
11
Hospitalizations
How Dangerous Is Chronic obstructive pulmonary disease From BIMEKIZUMAB?
Of the 14 reports, 11 (78.6%) required hospitalization.
Is Chronic obstructive pulmonary disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BIMEKIZUMAB. However, 14 reports have been filed with the FAERS database.
What Other Side Effects Does BIMEKIZUMAB Cause?
Psoriatic arthropathy (615)
Psoriasis (400)
Drug ineffective (293)
Inappropriate schedule of product administration (238)
Injection site pain (225)
Product dose omission issue (163)
Off label use (160)
Oral candidiasis (146)
Fatigue (138)
Therapy interrupted (138)
What Other Drugs Cause Chronic obstructive pulmonary disease?
ALBUTEROL (2,916)
TIOTROPIUM (2,895)
BUDESONIDE\FORMOTEROL (2,279)
FLUTICASONE\SALMETEROL (1,904)
ADALIMUMAB (1,712)
PREDNISONE (1,237)
FLUTICASONE FUROATE\UMECLIDINIUM\VILANTEROL TRIFENATATE (1,145)
MEPOLIZUMAB (1,107)
FLUTICASONE FUROATE\VILANTEROL TRIFENATATE (967)
DUPILUMAB (907)
Which BIMEKIZUMAB Alternatives Have Lower Chronic obstructive pulmonary disease Risk?
BIMEKIZUMAB vs BIMEKIZUMAB-BKZX
BIMEKIZUMAB vs BINIMETINIB
BIMEKIZUMAB vs BIOFLAVONOIDS
BIMEKIZUMAB vs BIOTIN
BIMEKIZUMAB vs BIPERIDEN